Bromocriptine and premenstrual symptoms: a survey of double blind trials.
Bromocriptine and premenstrual symptoms: a survey of double blind trials.
复制标题
DOI：
10.1097/00006254-198311000-00001
复制
发表时间：
1983-11-01
影响因子：
6.2
通讯作者：
Andersch, B
中科院分区：
文献类型：
--
作者：
Andersch, B
这是一项关于溴隐亭治疗经前症状的14项安慰剂对照研究的调查。没有实质性的支持，溴隐亭是一个有效的药物在经前期综合征作为一个实体。与安慰剂治疗相比，溴隐亭治疗期间的易怒、抑郁和焦虑等症状没有显著改善。溴隐亭似乎是治疗经前乳痛的选择，如果溴隐亭的剂量是至少5毫克，每天。因此，溴隐亭可能在经前综合征伴乳痛的特定病例中占有一席之地。
This is a survey of 14 placebo-controlled studies regarding the treatment of premenstrual symptoms with bromocriptine. There is no substantial support that bromocriptine is an effective drug in the premenstrual syndrome as an entity. Symptoms such as irritability, depression, and anxiety were not significantly improved during treatment with bromocriptine compared to placebo treatment. Bromocriptine appears to be the treatment of choice in premenstrual mastodynia if the dosage of bromocriptine is at least 5 mg daily. Bromocriptine may therefore have a place in selected cases of the premenstrual syndrome with associated mastodynia.